Related Experiment Video
Updated: Aug 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression
Keiko Kawai-Kowase1, Hiroko Sato, Yuko Oyama
1Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, 3-Maebashi, Gunma, Japan.
Objective:
Transforming growth factor-beta1 (TGFbeta1) and fibroblast growth factor (FGF) families play a pivotal role during vascular development and in the pathogenesis of vascular disease. However, the interaction of intracellular signaling evoked by each of these growth factors is not well understood. The present study was undertaken to examine the molecular mechanisms that mediate the effects of TGFbeta1 and basic FGF (bFGF) on smooth muscle cell (SMC) gene expression.
Methods And Results:
TGFbeta1 induction of SMC gene expression, including smooth muscle protein 22-alpha (SM22alpha) and smooth muscle alpha-actin, was examined in the pluripotent 10T1/2 cells. Marked increase in these mRNA levels by TGFbeta1 was inhibited by c-Src-tyrosine kinase inhibitors and protein synthesis inhibitor cycloheximide. Functional studies with deletion and site-directed mutation analysis of the SM22alpha promoter demonstrated that TGFbeta1 activated the SM22alpha promoter through a CC(A/T-rich)6GG (CArG) box, which serves as a serum response factor (SRF)-binding site. TGFbeta1 increased SRF expression through an increase in transcription of the SRF gene. In the presence of bFGF, TGFbeta1 induction of SMC marker gene expression was significantly attenuated. Transient transfection assays showed that bFGF significantly suppressed induction of the SM22alpha promoter-driven luciferase activity by TGFbeta1, whereas bFGF had no effects on the TGFbeta1-mediated increase in SRF expression and SRF:DNA binding activity. Mitogen-activated protein kinase kinase-1 (MEK1) inhibitor PD98059 abrogated the bFGF-mediated suppression of TGFbeta1-induced SMC gene expression.
Conclusions:
Our data suggest that bFGF-induced MEK/extracellular signal-regulated kinase signaling plays an antagonistic role in TGFbeta1-induced SMC gene expression through suppression of the SRF function. These data indicate that opposing effects of bFGF and TGFbeta1 on SMC gene expression control the phenotypic plasticity of SMCs.
Insights
Basic fibroblast growth factor (bFGF) antagonizes transforming growth factor-beta1 (TGFbeta1) signaling in smooth muscle cells. bFGF suppresses TGFbeta1-induced gene expression by inhibiting serum response factor (SRF) activity, impacting smooth muscle cell plasticity.
Area of Science:
- Vascular Biology
- Cell Signaling
- Molecular Mechanisms
Background:
- Transforming growth factor-beta1 (TGFbeta1) and fibroblast growth factor (FGF) families are crucial in vascular development and disease.
- The intracellular signaling interactions between TGFbeta1 and FGF, particularly basic FGF (bFGF), in smooth muscle cells (SMCs) are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms by which TGFbeta1 and bFGF influence SMC gene expression.
- To elucidate the interplay between TGFbeta1 and bFGF signaling pathways in regulating SMC phenotype.
Main Methods:
- Examined TGFbeta1 induction of SMC-specific genes (SM22alpha, smooth muscle alpha-actin) in 10T1/2 cells.
- Utilized c-Src-tyrosine kinase inhibitors, cycloheximide, and promoter analysis (deletion, site-directed mutation) focusing on the SRF-binding CArG box.
- Assessed the impact of bFGF on TGFbeta1-induced gene expression and promoter activity using transient transfection assays and MEK1 inhibitor (PD98059).
Main Results:
- TGFbeta1 significantly increased SM22alpha and smooth muscle alpha-actin mRNA levels, an effect inhibited by c-Src inhibitors and cycloheximide.
- TGFbeta1 activated the SM22alpha promoter via the SRF-binding CArG box and increased SRF gene transcription and expression.
- bFGF attenuated TGFbeta1-induced SMC marker gene expression by suppressing TGFbeta1's effect on the SM22alpha promoter activity, independent of SRF expression levels, an effect abrogated by PD98059.
Conclusions:
- bFGF-induced MEK/extracellular signal-regulated kinase (ERK) signaling antagonizes TGFbeta1-mediated SMC gene expression by inhibiting SRF function.
- The opposing actions of bFGF and TGFbeta1 on SMC gene expression are critical regulators of SMC phenotypic plasticity.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...